Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Pringy – page 8

93 clinical trials in Pringy, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Pringy at a glance
93
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

93 trials in Pringy

Open in trial search

Hepatitis D

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bulevirtide
  • Sponsor:Gilead Sciences Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Assistance Publique Hopitaux De Paris

Giant cell arteritis

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Centre Hospitalier Universitaire De Dijon
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Bortezomib
  • Sponsor:Centre Hospitalier Universitaire De Poitiers
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Groupe Francophone Des Myelodysplasies
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Clinipace Global Limited

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Pringy

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on colorectal cancer, lung cancer, and pancreatic adenocarcinoma. Studies evaluate novel combination therapies and treatment approaches for advanced stages of these diseases.

  • KRAS mutation therapies
  • Immunotherapy combinations
  • Targeted treatments

Emphasis on personalized medicine approaches and treatment optimization for patients with various cancer types.

02 Hematological Studies

Research initiatives examining treatments for multiple myeloma and lymphoma, including investigations of novel drug combinations and therapy duration optimization.

  • Daratumumab-based therapies
  • B-cell lymphoma treatments
  • Immunotherapy approaches

Focus on improving outcomes for patients with blood-related cancers through innovative therapeutic strategies.

03 Cardiovascular Research

Studies investigating treatments for atrial fibrillation and acute coronary syndrome, with emphasis on anticoagulation management and monitoring systems.

  • Telemedicine applications
  • Anticoagulation strategies
  • Remote monitoring systems

Integration of modern technology with traditional treatment approaches for better patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.